Doina C.
- Country
- Romania
- Department
- Clinica Diabet Zaharat, Nutritie si Boli Metabolice
Research Overview
- Evaluation of the Efficacy and Safety of Semaglutide with Reduced-Dose Insulin Glargine Versus Titrated Insulin Glargine in Type 2 Diabetes with Overweight
- Phase 2 Randomized, Double-Blind, Dose-Finding Study of Petrelintide Versus Placebo in Obesity or Overweight Patients with Weight-Related Comorbidities
- Efficacy and Safety Comparison of Once-Weekly Insulin Icodec Versus Once-Daily Insulin Glargine U100 with Insulin Aspart in Adults with Type 1 Diabetes
Data & Insights
Has run more than one trial at 7 of 105 partner sites.
Specializations
Metabolic Health
This investigator specializes in the management of Type 2 Diabetes, with particular focus on treatment optimization using combination therapies including injectable medications and insulin management strategies.
- Diabetes Management
- Insulin Therapy Optimization
- Glycemic Control
The research explores innovative approaches to achieving glycemic targets while optimizing insulin dosing regimens.
Weight Management
The investigator focuses on advanced therapeutic approaches for obesity treatment and weight management, particularly examining novel pharmaceutical interventions combined with lifestyle modifications.
- Obesity Treatment
- Weight Loss Interventions
- Lifestyle Integration
Their work encompasses comprehensive approaches to weight management incorporating dietary and physical activity components.
Metabolic Comorbidities
The investigator addresses the interconnection between obesity and type 2 diabetes, focusing on therapeutic strategies that target multiple metabolic conditions simultaneously.
- Metabolic Disease Management
- Combination Therapy Approaches
- Comorbidity Treatment
Research includes evaluation of integrated treatment approaches for patients with multiple metabolic conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
